Each year, over 6 million dogs are diagnosed with cancer, a figure that notably exceeds the 1.9 million human cancer incidence rate. In the U.S., there are merely nine approved cancer treatments for veterinary use, many of which rely on outdated technologies. This scarcity is compounded by limited insurance coverage, hindering access to crucial care for numerous pets and their families.
Jenga is on a mission to arm veterinarians with cutting-edge, effective cancer treatments. We strive to broaden the accessibility of advanced cancer care for pets in need, aiming to transform the landscape of veterinary oncology.
Committed to overcoming existing barriers in cancer treatment, Jenga is forging a path toward a future where all pets can enjoy healthier, fuller lives. By expanding therapeutic innovations, we seek to improve health outcomes for pets, providing their families with reassurance and hope. Through relentless innovation and unwavering dedication, Jenga is set to elevate veterinary care, guaranteeing the best possible treatments are within reach for pets everywhere.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Carmel, Indiana 46032, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.jengabio.com
- Keywords
- Leawood.
- HQ
- Carmel, Indiana
Jenga Biosciences Questions
Jenga Biosciences's website is http://www.jengabio.com
Jenga Biosciences's LinkedIn profile is https://www.linkedin.com/company/jengabio
Jenga Biosciences has
2 employees.
View email and phone details for 2
employees at Jenga Biosciences.
Jenga Biosciences's industry is
Pharmaceutical Manufacturing
Jenga Biosciences's top competitors are
Borealis Ventures,
Elias Animal Health,
3oe Scientific,
Okava,
Tartar Shield,
Avviare Consulting,
Indiana Biotech And Pharmaceutical Network,
Verility, Inc.,
Aratana Therapeutics Inc.,
Insylo Technologies.
Jenga Biosciences's categories are Pharmaceutical Manufacturing
Jenga Biosciences's founding year is 2024
